IP
ZOM

Intellectus Partners’s Zomedica Corp. ZOM Stock Holding History

Intellectus Partners’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,180
Closed -$5.12K – 283
2023
Q1 		$5.12K Hold
24,180
– – ﹤0.01% 253
2022
Q4 		$3.94K Hold
24,180
– – ﹤0.01% 260
2022
Q3 		$5K Sell
24,180
-7,000
-22% -$1.85K ﹤0.01% 260
2022
Q2 		$7K Hold
31,180
– – ﹤0.01% 250
2022
Q1 		$11K Hold
31,180
– – ﹤0.01% 233
2021
Q4 		$10K Hold
31,180
– – ﹤0.01% 269
2021
Q3 		$16K Buy
+31,180
New +$18.4K ﹤0.01% 272

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return